Luigi Pianese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Luigi Pianese has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Antonella Monticelli
2 shared publicationsIrene De Biase
2 shared publicationsSergio Cocozza
2 shared publicationsStelio Varrone
2 shared publicationsAlessandro Filla
1 shared publicationAngela Tammaro
1 shared publication
Latest Publications
- Open Access
- 1 November 2002
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 11 (23) , 2989-2996
Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells
The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin, encoded by the X25 gene, causes Friedreich ataxia (FRDA), the most common form of recessive hereditary ataxia. Increasing evidence underlines the pathogenetic role of oxidative stress in this disease. We generated an in vitro cellular model of regulated human frataxin overexpression. We identified, by differential display technique, the mitogen activated protein kinase kinase 4 mRNA down regulation in frataxin overexpressing cells. We studied the stress kinases pathway in this cellular model and in fibroblasts from FRDA patients. Frataxin overexpression reduced c-Jun N-terminal kinase phosphorylation. Furthermore, exposure of FRDA fibroblasts to several forms of environmental stress caused an up regulation of phospho-JNK and phospho-c-Jun. To understand if this susceptibility results in cell death, we have investigated the involvement of caspases. A significantly higher activation of caspase-9 was observed in FRDA versus control fibroblasts after serum-withdrawal. Our findings suggest the presence, in FRDA patient cells, of a ‘hyperactive’ stress signaling pathway. The role of frataxin in FRDA pathogenesis could be explained, at least in part, by this hyperactivity.
- 1 November 2002
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 11 (23) , 2989-2996
Open AccessUp-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells
The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin, encoded by the X25 gene, causes Friedreich ataxia (FRDA), the most common form of recessive hereditary ataxia. Increasing evidence underlines the pathogenetic role of oxidative stress in this disease. We generated an in vitro cellular model of regulated human frataxin overexpression. We identified, by differential display technique, the mitogen activated protein kinase kinase 4 mRNA down regulation in frataxin overexpressing cells. We studied the stress kinases pathway in this cellular model and in fibroblasts from FRDA patients. Frataxin overexpression reduced c-Jun N-terminal kinase phosphorylation. Furthermore, exposure of FRDA fibroblasts to several forms of environmental stress caused an up regulation of phospho-JNK and phospho-c-Jun. To understand if this susceptibility results in cell death, we have investigated the involvement of caspases. A significantly higher activation of caspase-9 was observed in FRDA versus control fibroblasts after serum-withdrawal. Our findings suggest the presence, in FRDA patient cells, of a ‘hyperactive’ stress signaling pathway. The role of frataxin in FRDA pathogenesis could be explained, at least in part, by this hyperactivity.
- 1 March 2002
- Published by Elsevier in Neuroscience Letters
- Vol. 320 (3) , 137-140
Identification of a novel transcript of X25, the human gene involved in Friedreich ataxia
- 1 March 2002
- Published by Elsevier in Neuroscience Letters
- Vol. 320 (3) , 137-140
Identification of a novel transcript of X25, the human gene involved in Friedreich ataxia
- 1 April 1992
- Published by American Diabetes Association in Diabetes Care
- Vol. 15 (4) , 591-592
Mutations in Insulin-Receptor Gene: Val996 Allele in White NIDDM Patients
- 1 April 1992
- Published by American Diabetes Association in Diabetes Care
- Vol. 15 (4) , 591-592
Mutations in Insulin-Receptor Gene: Val996 Allele in White NIDDM Patients